MAJI (Exousia Pro) Pretax Margin %: % (As of Jan. 2021)


What is Exousia Pro Pretax Margin %?

Exousia Pro MAJI +13.92% Pretax Margin % is % as of Jan. 2021.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Exousia Pro's Pre-Tax Income for the three months ended in Jan. 2021 was $-0.13 Mil. Exousia Pro's Revenue for the three months ended in Jan. 2021 was $0.00 Mil. Therefore, Exousia Pro's pretax margin for the quarter that ended in Jan. 2021 was %.

The historical rank and industry rank for Exousia Pro's Pretax Margin % or its related term are showing as below:


MAJI's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.5
* Ranked among companies with meaningful Pretax Margin % only.

Exousia Pro  (OTCPK:MAJI) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Exousia Pro Pretax Margin % Related Terms

Exousia Pro Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Exousia Pro's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exousia Pro Pretax Margin % Chart

Exousia Pro Annual Data
Trend Apr11 Apr12 Apr18 Apr19
Pretax Margin %
0.00 0.00 0.00 0.00

Exousia Pro Quarterly Data
Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MAJI vs HCCH, GRNV, AGBA: Pretax Margin % Comparison

For the Biotechnology subindustry, Exousia Pro's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exousia Pro Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exousia Pro's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Exousia Pro's Pretax Margin % falls into.


Exousia Pro Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Exousia Pro's Pretax Margin for the fiscal year that ended in Apr. 2019 is calculated as

Pretax Margin=Pre-Tax Income (A: Apr. 2019 )/Revenue (A: Apr. 2019 )
=-0.125/0
= %

Exousia Pro's Pretax Margin for the quarter that ended in Jan. 2021 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jan. 2021 )/Revenue (Q: Jan. 2021 )
=-0.134/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Exousia Pro (MAJI) has a Pretax Margin % of % as of Jan. 2021. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Exousia Pro and its competitors.
Is Exousia Pro's Pretax Margin % too high?
Exousia Pro's current Pretax Margin % is %.
How does Exousia Pro's Pretax Margin % compare to HCCH and GRNV?
Exousia Pro's Pretax Margin % of % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Exousia Pro and its competitors. Exousia Pro's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exousia Pro stock overvalued right now?
Exousia Pro (MAJI) has a current Pretax Margin % of %. The current Pretax Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Exousia Pro (MAJI), the current Pretax Margin % is % as of Jan. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exousia Pro Business Description

Address 7901 4th Street North, No. 23494, St. Petersburg, FL, USA, 33702
Exousia Pro Inc is a exosome-based biotechnology, develops and manufactures mammalian and plant-based exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company is developing new ways to exploit the therapeutic potential of exosomes, initially focused in the field of oncology. The platform technology of the company also helps treating a broad spectrum of viral infections.